× Industry Reports Services Press Release Contact us About us

North America Cell Line Development Market Size By Product (Reagents & Media, Equipment {Incubator, Centrifuge, Bioreactor, Storage Equipment, Microscope}, Accessories & Consumables), By Source (Mammalian, Non-Mammalian {Insects, Amphibians}), By Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research), Industry Analysis Report, Regional Outlook (U.S., Canada), Application Potential, Competitive Market Share & Forecast, 2018 - 2024
Published Date: September 2018 | Publisher: Graphical Research Report ID: GR1067 | Delivery : PDF  Request Free Sample

Report Content
Chapter 1.    Methodology 
1.1.    Methodology
1.2.    Market definitions
1.3.    Forecast parameters
1.4.    Data sources
1.4.1.    Secondary
1.4.1.1.    Paid sources
1.4.1.2.    Unpaid sources    
1.4.2.    Primary 
Chapter 2.    Executive Summary
2.1.    North America cell line development market industry 3600 synopsis, 2013 – 2024
Chapter 3.    North America Cell Line Development Market Industry Insights
3.1.    Industry segmentation
3.2.    Industry landscape, 2013 – 2024
3.3.    Industry impact forces
3.3.1.    Growth drivers
3.3.1.1.    Growing vaccine production
3.3.1.2.    Increasing cancer prevalence
3.3.1.3.    Growth in biotechnology industry
3.3.1.4.    Innovations in biologics due to patent expirations
3.3.1.5.    Rising demand for monoclonal antibodies
3.3.1.6.    Technological innovation in cell line development 
3.3.2.    Industry pitfalls & challenges
3.3.2.1.    Issues related to stem cell research
3.4.    Growth potential analysis
3.4.1.    By product
3.4.2.    By source
3.4.3.    By cell-line type
3.4.4.    By application
3.5.    Competitive landscape, 2017
3.5.1.    Strategy dashboard
3.6.    Porter’s analysis
3.7.    PESTEL analysis
Chapter 4.    North America Cell Line Development Market, By Product
4.1.    Key segment trends
4.2.    Reagents and media
4.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
4.3.    Equipment
4.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.2.    Incubators
4.3.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.3.    Centrifuges
4.3.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.4.    Bioreactors
4.3.4.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.5.    Storage equipment
4.3.5.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.6.    Microscopes
4.3.6.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.4.    Accessories
4.4.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
Chapter 5.    North America Cell Line Development Market, By Source
5.1.    Key segment trends
5.2.    Mammalian
5.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
5.3.    Non-mammalian
5.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
5.3.2.    Insects
5.3.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
5.3.3.    Amphibians
5.3.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
Chapter 6.    North America Cell Line Development Market, By Cell Line Type
6.1.    Key segment trends
6.2.    Recombinant cell lines
6.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
6.3.    Hybridomas
6.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
6.4.    Continuous cell lines
6.4.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
6.5.    Primary cell lines
6.5.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
Chapter 7.    North America Cell Line Development Market, By Application
7.1.    Key segment trends
7.2.    Bioproduction
7.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
7.3.    Drug discovery
7.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
7.4.    Toxicity testing
7.4.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
7.5.    Tissue engineering
7.5.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
7.6.    Research
7.6.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
Chapter 8.    North America Cell Line Development Market, By Country
8.1.    Key regional trends
8.2.    North America
8.2.1.    Market estimates and forecast by country, 2013 – 2024(USD Million)
8.2.2.    Market estimates and forecast by product, 2013 – 2024(USD Million)    
8.2.3.    Market estimates and forecast by source, 2013 – 2024(USD Million)
8.2.4.    Market estimates and forecast by cell line type, 2013 – 2024(USD Million)
8.2.5.    Market estimates and forecast by application, 2013 – 2024(USD Million)
8.2.6.    U.S.
8.2.6.1.    Market estimates and forecast by product, 2013 – 2024(USD Million)
8.2.6.2.    Market estimates and forecast by source, 2013 – 2024(USD Million)
8.2.6.3.    Market estimates and forecast by cell line type, 2013 – 2024(USD Million)
8.2.6.4.    Market estimates and forecast by application, 2013 – 2024(USD Million)
8.2.7.    Canada
8.2.7.1.    Market estimates and forecast by product, 2013 – 2024(USD Million)
8.2.7.2.    Market estimates and forecast by source, 2013 – 2024(USD Million)
8.2.7.3.    Market estimates and forecast by cell line type, 2013 – 2024(USD Million)
8.2.7.4.    Market estimates and forecast by application, 2013 – 2024(USD Million)
Chapter 9.    Company Profiles
9.1.    GE Healthcare
9.1.1.    Business overview
9.1.2.    Financial data
9.1.3.    Product landscape
9.1.4.    Strategic outlook
9.2.    Thermo Fisher Scientific Inc.
9.2.1.    Business overview
9.2.2.    Financial data
9.2.3.    Product landscape
9.2.4.    Strategic outlook
9.3.    Lonza Group AG
9.3.1.    Business overview
9.3.2.    Financial data
9.3.3.    Product landscape
9.3.4.    Strategic outlook
9.4.    Sigma-Aldrich Corporation (Merck)
9.4.1.    Business overview
9.4.2.    Financial data
9.4.3.    Product landscape
9.4.4.    Strategic outlook
9.5.    WuXi AppTec
9.5.1.    Business overview
9.5.2.    Financial data
9.5.3.    Product landscape
9.5.4.    Strategic outlook
9.6.    Sartorius Stedim Biotech GmbH
9.6.1.    Business overview
9.6.2.    Financial data
9.6.3.    Product landscape
9.6.4.    Strategic outlook
9.7.    Corning Inc.
9.7.1.    Business overview
9.7.2.    Financial data
9.7.3.    Product landscape
9.7.4.    Strategic outlook
9.8.    Vista Biologicals Co.
9.8.1.    Business overview
9.8.2.    Financial data
9.8.3.    Product landscape
9.8.4.    Strategic outlook
9.9.    Paragon Bioservices
9.9.1.    Business overview
9.9.2.    Financial data
9.9.3.    Product landscape
9.9.4.    Strategic outlook
9.10.    Patheon
9.10.1.    Business overview
9.10.2.    Financial data
9.10.3.    Product landscape
9.10.4.    Strategic outlook
9.11.    NAEJA RGM Pharmaceuticals
9.11.1.    Business overview
9.11.2.    Financial data
9.11.3.    Product landscape
9.11.4.    Strategic outlook
9.12.    GVK BIO
9.12.1.    Business overview
9.12.2.    Financial data
9.12.3.    Product landscape
9.12.4.    Strategic outlook
9.13.    Progenitor Cell Therapy (PCT)
9.13.1.    Business overview
9.13.2.    Financial data
9.13.3.    Product landscape
9.13.4.    Strategic outlook
9.14.    Apath LLC
9.14.1.    Business overview
9.14.2.    Financial data
9.14.3.    Product landscape
9.14.4.    Strategic outlook
9.15.    Cyagen
9.15.1.    Business overview
9.15.2.    Financial data
9.15.3.    Product landscape
9.15.4.    Strategic outlook

Data Tables
TABLE 1.    North America cell line development industry 3600 synopsis, 2013 – 2024
TABLE 2.    Industry impact forces
TABLE 3.    Reagents and media market size, by country, 2013 – 2024 (USD Million)
TABLE 4.    Cell line development equipment market size, by country, 2013 – 2024 (USD Million)
TABLE 5.    Incubators market size, by country, 2013 – 2024 (USD Million)
TABLE 6.    Centrifuges market size, by country, 2013 – 2024 (USD Million)
TABLE 7.    Bioreactors market size, by country, 2013 – 2024 (USD Million)
TABLE 8.    Storage equipment market size, by country, 2013 – 2024 (USD Million)
TABLE 9.    Microscopes market size, by country, 2013 – 2024 (USD Million)
TABLE 10.    Cell line development accessories market size, by country, 2013 – 2024 (USD Million)
TABLE 11.    Mammalian cell line development market size, by country, 2013 – 2024 (USD Million)
TABLE 12.    Non-mammalian cell line development market size, by country, 2013 – 2024 (USD Million)
TABLE 13.    Non-mammalian insects cell line development market size, by country, 2013 – 2024 (USD Million)
TABLE 14.    Non-mammalian amphibians cell line development market size, by country, 2013 – 2024 (USD Million)
TABLE 15.    Recombinant cell lines market size, by country, 2013 – 2024 (USD Million)
TABLE 16.    Hybridomas market size, by country, 2013 – 2024 (USD Million)
TABLE 17.    Continuous cell lines market size, by country, 2013 – 2024 (USD Million)
TABLE 18.    Primary cell lines market size, by country, 2013 – 2024 (USD Million)
TABLE 19.    Bioproduction market size, by country, 2013 – 2024 (USD Million)
TABLE 20.    Drug discovery market size, by country, 2013 – 2024 (USD Million)
TABLE 21.    Toxicity testing market size, by country, 2013 – 2024 (USD Million)
TABLE 22.    Tissue engineering market size, by country, 2013 – 2024 (USD Million)
TABLE 23.    Research market size, by country, 2013 – 2024 (USD Million)
TABLE 24.    North America cell line development market, by country 2013 - 2024 (USD Million)
TABLE 25.    North America cell line development market, by product, 2013 - 2024 (USD Million)
TABLE 26.    North America cell line development market, by equipment, 2013 - 2024 (USD Million)
TABLE 27.    North America cell line development market, by source, 2013 - 2024 (USD Million)
TABLE 28.    North America cell line development market, by non-mammalian source 2013 - 2024 (USD Million)
TABLE 29.    North America cell line development market, by type of cell lines, 2013 - 2024 (USD Million)
TABLE 30.    North America cell line development market, by application, 2013 - 2024 (USD Million)
TABLE 31.    U.S. cell line development market, by product, 2013 - 2024 (USD Million)
TABLE 32.    U.S. cell line development market, by equipment, 2013 - 2024 (USD Million)
TABLE 33.    U.S. cell line development market, by source, 2013 - 2024 (USD Million)
TABLE 34.    U.S. cell line development market, by non-mammalian source 2013 - 2024 (USD Million)
TABLE 35.    U.S. cell line development market, by type of cell lines, 2013 - 2024 (USD Million)
TABLE 36.    U.S. cell line development market, by application, 2013 - 2024 (USD Million)
TABLE 37.    Canada cell line development market, by product, 2013 - 2024 (USD Million)
TABLE 38.    Canada cell line development market, by equipment, 2013 - 2024 (USD Million)
TABLE 39.    Canada cell line development market, by source, 2013 - 2024 (USD Million)
TABLE 40.    Canada cell line development market, by non-mammalian source 2013 - 2024 (USD Million)
TABLE 41.    Canada cell line development market, by type of cell lines, 2013 - 2024 (USD Million)
TABLE 42.    Canada cell line development market, by application, 2013 - 2024 (USD Million)

Charts & Figures
FIG 1.    Industry segmentation
FIG 2.    North America cell line development market, 2013 - 2024 (USD Million)
FIG 3.    Cancer incidence in the U.S., 2005-2015 (Million)
FIG 4.    Growth potential analysis, by product
FIG 5.    Growth potential analysis, by source
FIG 6.    Growth potential analysis, by cell line type
FIG 7.    Growth potential analysis, by application
FIG 8.    Strategy dashboard
FIG 9.    Porter’s analysis
FIG 10.    PESTEL analysis
FIG 11.    Rates of new cancer cases in U.S. (State wise data per 100,000 people in the year 2013)
 


Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]